Abstract
The COVID-19 pandemic heightened interest in circular RNA (C-RNA) for RNA therapeutics, offering advantages over linear mRNAs. Circular mRNA facilitates uncapped molecule development, and C-RNAs ensure stability in RNA interference therapeutics. The synthesis method, RNA ligation, is employed in C-RNA-based therapeutics. Stable DNA-RNA hybrid constructs enable efficient RNA ligase-based circularization.
Original language | English |
---|---|
Pages (from-to) | 15529-15532 |
Number of pages | 4 |
Journal | Nanoscale |
Volume | 16 |
Issue number | 33 |
DOIs | |
State | Published - 5 Aug 2024 |